gern has been forgoteen for many years. Investors have been tired of this company and that's the reason why it is not performing. It is not about the profit or revenue, it is about the perspective. Take AVL for example, it has nothing, but just the rare earth element prespective, but it keeps soaring.
I feel sorry for the ones that have been holding gern for the last decade
I don't know about the rest of the Geron investors on this board, Watert11, but the reason I hang on to my Geron stock probably has something to do with my long-term masochistic tendencies.
Watching my Geron investment tank reinforces my deeply-held convictions that I'm totally worthless and DESERVE any financial losses that come my way.
I thank you, Watert11, for taking time from your busy schedule to castigate and belittle me. I hope you'll come back again and further ridicule my sorry a.s.s.
Don't beat yourself up, man. I, too, am a long-term investor and I intend to hold my shares until we finally get definitive test data. Remember, Geron is not a chocolate maker. It does not produce vehicles or oil. It is at the forefront of Biotechnology. Its submission to the FDA for spinal injections covered millions of pages, and cost millions of dollars. Just be patient. At some point in the future you will rejoice, as I will. I am completely certain of that.
Everything comes to he who waits.
Cry me a river. You feel sorry for us poor Geron investors? Well, don't bother, as many of us understand these biotech issues, the frustrations and time periods involved. Here as with many, ALL that will count is whether you are in when huge value appreciations occur. And on that subject you sound clueless, other than to review history, which everyone knows about. Now get back to crying, weeping, selling short or whatever!LOL
4/01/2011 not an april fools joke - Geron (Nasdaq: GERN): Using its cell technology, Geron is developing GRNVAC1 for treatment of acute myelogenous leukemia (AML). In a Phase II trial, 13 out of 21 patients were in complete remission, while 7 out of 11 patients who were considered at high risk for relapse remained in complete remission for up to 30 months.
Well. We are not ALL Geron stock holders have been here for the last 3, or 5, or 10 years.!!!
Some are relatively new.
The research is slow - I'll give you that. But the resuts have been pretty amazing.!! And now they are in clinical trias....
Now is not the time to sell.... the new chapter is just beginning (a chapter that will be a couple years and revolve around the trial results + partnerships). Dont put the book down yet - you'll miss the exciting parts.
I am Long, and I am profitable.
Any guesses when the current hoax aka pump and dump is exposed ?
I'm thinking they let this one run thru next friday fer sure. Sell as many calls as possible...wind up the short interest a few million...let the naked asians pile on...yup.
Sad it's even allowed...huh ? America the great....right...got it.